Interestingly, a marker composed of both measures, namely IL-6/LC, appears to be promising because elevated IL-6/LC predicts mortality in both patients with severe (SEV) COVID-19 [14] according to the National Institutes of Health (NIH) classification [15] and in those with respiratory failure not requiring intensive care [16]. The gene discussed is IL6; the disease is respiratory failure.